https://news.augustaheadlines.com/story/525940/sukar-redefines-the-swedish-candy-experience-with-bold-flavors-vegan-choices-and-global-delivery.html 2025-07-15T13:00:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/525918/scratch-and-play-llc-debuts-interactive-posters-featuring-horror-classics-and-major-league-baseball-stadiums.html 2025-07-15T12:06:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/525927/find-the-lowest-prices-on-deftones-2025-tour-tickets-with-city10-discount-at-capitalcityticketscom-all-levels-of-seating-on-sale.html 2025-07-15T10:58:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/525926/atrial-fibrillation-pipeline-2025-moa-and-roa-insights-clinical-trials-status-and-key-companies-involved-by-delveinsight-bayer-johnson-and-johnson-bristol-myerssquibb-daiichi-sankyo-pfizer.html 2025-07-15T10:52:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/525925/peripheral-neuropathic-pain-pipeline-2025-fda-updates-therapy-innovations-and-clinical-trial-landscape-analysis-by-delveinsight-trevena-afasci-lexicon-pharma-haisco-pharma-vertex-pharma.html 2025-07-15T10:30:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/525924/justresellit-introduces-digital-book-reselling-system-with-professional-content-library-and-brand-customization-features.html 2025-07-15T10:04:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/525923/emphysema-pipeline-2025-moa-roa-and-clinical-trial-insights-explored-by-delveinsight-kamada-ltd-hoffmannla-roche-aeris-therapeutics-grifols-therapeutics-sanofi.html 2025-07-15T09:56:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/525922/necrotizing-enterocolitis-pipeline-2025-detailed-clinical-trials-and-fdaapproved-therapies-review-by-delveinsight-abbott-astellas-pharma-bayer-becton-bristolmyers-squibb-daiichi-sankyo.html 2025-07-15T09:30:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/525921/boc-sciences-to-showcase-innovative-solutions-at-acs-fall-2025.html 2025-07-15T09:20:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/525920/status-epilepticus-pipeline-2025-key-companies-moa-roa-and-clinical-trials-evaluation-by-delveinsight-marinus-pharmac-pfizer-ucb-biopharma-rafa-laboratories-sage-therapeutics.html 2025-07-15T08:48:04+00:00 daily 1.0